AstraZeneca Dunkerque Production (manufacturing, primary packaging, secondary packaging, quality control and batch release)
UkraineAll drugs from this manufacturer
-
The drug is intended for the maintenance therapy of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) if other combination therapies do not provide sufficient effect.
Dosage form: inhalation, suspension under pressure
Active substance Dosage formoterol 5 mcg glycopyrronium 7.2 mcg budesonide 160 mcg ATC: R03AL11